All trials View full record on ClinicalTrials.gov
NCT04430517EARLY PHASE1ACTIVE NOT RECRUITINGAPOE4-explicit
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
Eligibility check — Phoenix members
Phoenix members see for THIS trial:
- APOE genotype match
- Cognitive status fits inclusion
- Specific exclusions flagged
- Distance to nearest site
Sites
1 location
Start
2022-03-02
Interventions tested
- DRUGNicotinamide riboside